P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index.
Rocío Sedaño, Vipul Jairath(Western University), S C Mcfarlane, Greg Rosenfeld(British Columbia Centre on Substance Use), A Marchal(Centre hospitalier Emile Roux), B Bojic, Mark Samaan(New Leaders), Ailsa Hart(St Mark's Hospital), G R D’Haens, Christopher Ma(University of Calgary), M Hogan, Roger Feakins(Royal Free London NHS Foundation Trust), Brian Bressler(University of British Columbia), Guangyong Zou(Western University), J Rémillard, Simon Travis(University of Oxford), R. E. Kirsch(Mount Sinai Hospital), B E Sands(Icahn School of Medicine at Mount Sinai), Mark S. Silverberg(Sinai Health System), B G Feagan(Western University), Remo Panaccione(University of Calgary)
Cited by 5
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k